Delivery Order SPE2DB20D1100-SPE2DB24FA4Y4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA 40 MG/0.8 ML syringes. The contract, valued at $8,148.80, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,971.29 order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract for HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,847.20 contract has a completion date of February 13, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,385.37 award has a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563557780 HUMIRA 40 MG/0.8 ML SYRINGES. The contract has a completion date of February 6, 2024 and a potential value of $3,325.28. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products to support military treatment programs and facilities. This delivery order is part of a larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HUMIRA(CF) 20 MG/0.2 ML syringes. The contract is a firm fixed price delivery order with a potential value of $2,770.74 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,847.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HUMIRA 40 MG/0.8 ML SYRINGES. This award is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,636.62 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HUMIRA(CF) 40 MG/0.4 ML syringes. This order was issued under a $999,999,999.00 indefinite delivery contract awarded to Amerisourcebergen Drug Corp as the sole prime contractor. The contract provides a vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,963.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA 40 MG/0.8 ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $6,993.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA 40 MG/0.8 ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4Y4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The potential value of this contract is $6,597.12, with a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 2/29/24 |